Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial

Francisco Javier Basterra-Gortari; Miguel Ruiz‐Canela; Miguel Ángel Martínez‐González; Nancy Babió; José V. Sorlí; Montserrat Fitó; Emilio Ros; Enrique Gómez‐Gracia; Miquel Fiol; José Lapetra; Ramón Estruch; Luís Serra‐Majem; Xavier Pintó; José I. González; Mònica Bulló; Olga Castañer; Ángel M. Alonso‐Gómez; Luis Forga; Fernando Arós

doi:10.2337/dc18-2475

Abstract

This is the authors' abstract. We don't add key points for this paper.

Among participants with type 2 diabetes, a Med-EatPlan + EVOO may delay the introduction of new-onset glucose-lowering medications. The Med-EatPlan did not result in a significantly lower need for insulin.

Ask about this paper

Answers are grounded in this paper and cite their sources.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Basterra-Gortari et al. (2019) studied this question.

synapsesocial.com/papers/69d80a4145af6083e6ae2aa6 https://doi.org/10.2337/dc18-2475

View Full Paper

Ask AI

Bookmark

Share

Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial

Abstract

Ask about this paper

Discussion

Cite This Study

Effects of a Mediterranean Eating Plan on the Need for Glucose-Lowering Medications in Participants With Type 2 Diabetes: A Subgroup Analysis of the PREDIMED Trial

Abstract

Ask about this paper

Discussion

Cite This Study

Keep reading

Keep reading